Welcome to the Cognitive-Communication in Aging and Neurogenic Disorders Laboratory
Welcome to the homepage for the Cognitive-Communication in Aging and Neurogenic Disorders Laboratory (CCANDL). Our team seeks to understand preclinical signs of dementia, shed light on possible methods of early identification, and explore innovative intervention options. We seek interdisciplinary collaboration and community input for our projects.
Please feel free to contact our team at any time with questions about our work or how you can get involved!
Primary Aims of Our Lab
Understanding neural mechanisms of speech/language in individuals with normal aging, preclinical Alzheimer’s disease, Alzheimer’s Disease, Mild CognitiveImpairment (MCI), and other forms of dementia.
Design and testing of identification methods of early cognitive change in the presence of AD biomarkers.
Analysis of naturalistic speech-language samples as a means of gaining insight from subtle changes to communication in the context of aging and neurodegenerative diseases.
Creation of multimodal therapeutic interventions to address cognitive-communication difficulties in MCI and dementia due to neurodegenerative disease.
News from CCANDL
CCANDL is thrilled as Elizabeth Evans’ paper Preliminary assessment of connected speech and language as marker for cognitive change in late middle-aged Black/African American adults at risk for Alzheimer’s disease has been published in Routledge’s Aphasiology. …
CCANDL’s Hannah Belay’s abstract, Communication Behaviors that Manifest as Episodes of Lucidity in Persons Living with Dementia: A Scoping Review, was selected for a lightening presentation at the 2021 UW-Madison Alzheimer’s Disease and Related Disorders …
CCANDL is proud to announce that graduate research assistant and student clinician, Elizabeth Evans, was nominated for the UW System Board of Regents’ 2021 Diversity Award. (Link to the announcement here). “These awards recognize individuals …
CCANDL’s Principal Investigator Dr. Kimberly Mueller Ph.D., CCC-SLP, has received an R01 grant from the NIH for her project entitled, Novel Story Recall Measures as Indicators of Cognitive Decline Associated with Alzheimer’s Disease and Related …
- More News